Verition Fund Management’s Aldeyra Therapeutics ALDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-37,505
| Closed | -$216K | – | 2872 |
|
2025
Q1 | $216K | Buy |
+37,505
| New | +$216K | ﹤0.01% | 2366 |
|
2024
Q4 | – | Sell |
-33,530
| Closed | -$181K | – | 2551 |
|
2024
Q3 | $181K | Sell |
33,530
-186,297
| -85% | -$1M | ﹤0.01% | 2215 |
|
2024
Q2 | $728K | Sell |
219,827
-720,571
| -77% | -$2.39M | ﹤0.01% | 1288 |
|
2024
Q1 | $3.08M | Sell |
940,398
-384,436
| -29% | -$1.26M | 0.02% | 700 |
|
2023
Q4 | $4.65M | Buy |
1,324,834
+389,561
| +42% | +$1.37M | 0.04% | 427 |
|
2023
Q3 | $6.25M | Buy |
935,273
+5,199
| +0.6% | +$34.7K | 0.07% | 315 |
|
2023
Q2 | $7.8M | Sell |
930,074
-634,954
| -41% | -$5.33M | 0.1% | 235 |
|
2023
Q1 | $15.5M | Buy |
1,565,028
+6,706
| +0.4% | +$66.6K | 0.22% | 96 |
|
2022
Q4 | $10.8M | Sell |
1,558,322
-843,917
| -35% | -$5.87M | 0.17% | 116 |
|
2022
Q3 | $12.8M | Buy |
2,402,239
+501,048
| +26% | +$2.68M | 0.14% | 128 |
|
2022
Q2 | $7.59M | Sell |
1,901,191
-204,716
| -10% | -$817K | 0.15% | 152 |
|
2022
Q1 | $9.36M | Buy |
2,105,907
+739,206
| +54% | +$3.29M | 0.11% | 124 |
|
2021
Q4 | $5.47M | Buy |
1,366,701
+718,494
| +111% | +$2.87M | 0.04% | 233 |
|
2021
Q3 | $5.69M | Buy |
648,207
+120,376
| +23% | +$1.06M | 0.05% | 172 |
|
2021
Q2 | $5.98M | Buy |
527,831
+111,114
| +27% | +$1.26M | 0.05% | 149 |
|
2021
Q1 | $4.95M | Buy |
416,717
+219,963
| +112% | +$2.61M | 0.06% | 151 |
|
2020
Q4 | $1.35M | Sell |
196,754
-99,426
| -34% | -$682K | 0.01% | 362 |
|
2020
Q3 | $2.2M | Buy |
296,180
+274,180
| +1,246% | +$2.03M | 0.04% | 182 |
|
2020
Q2 | $92K | Buy |
+22,000
| New | +$92K | ﹤0.01% | 928 |
|
2019
Q2 | – | Sell |
-275,205
| Closed | -$2.49M | – | 950 |
|
2019
Q1 | $2.49M | Buy |
275,205
+124,400
| +82% | +$1.12M | 0.1% | 137 |
|
2018
Q4 | $1.25M | Buy |
+150,805
| New | +$1.25M | 0.09% | 182 |
|